Increasing laboratory researches and clinical tests indicated that non-IgG antibodies have unique therapeutic advantages over IgGs in the treatment of human diseases, especially tumors. In order to discover more efficient tumor-therapeutic strategies and provide more comprehensive antibody services, Creative Biolabs has devoted large quantities of time and energy to the non-IgG antibodies research and development. Here, we are more than pleased to offer one-stop and fully customized service about non-IgG antibodies applied for thymoma treatment.